Call for Abstracts Guidelines

PRIMM presents a fantastic opportunity for multi-disciplinary practitioners and researchers involved in medicines management and optimisation practice, quality improvement and research to network, share and learn.

Abstracts accepted for PRIMM are published in Pharmacoepidemiology and Drug Safety https://onlinelibrary.wiley.com/journal/10991557.


Submission Process

Using the guidance below, construct your abstract in a WORD document (maximum of 500 words) and send it to primmad17@gmail.com

All abstracts received will be considered for oral and/or poster presentation.

Abstracts should be self-contained on a single side of A4, suitable for reproduction in the delegate conference packs and for publication in the Journal of Pharmacoepidemiology and Drug Safety.

Use a short, informative title in block capital letters.

List names of authors (surname first) beginning with the presenting author. Follow with name(s) of institution(s) and location. Author forenames/surnames should be explicit: to minimise ambiguity it is recommended that first initials and last (family) name are used.

Describe briefly the aim/objectives of the study, unless they are self-evident from the title.

Include a brief description of method(s).

Describe results in sufficient detail to support conclusions.

End the abstract with a conclusion.

Further Guidelines for preparing an Abstract

Please keep to the order given for Title, Authors, Affiliation & Research, adhering to the formatting as shown throughout (caps, lower case, superscript, colons, bold). This will cut down on editing – resulting in an early publication date.

Draft outline

ABSTRACT TITLE

*Bloggs J.1,3, Smith M.S.2, and Jones F.3 [Lead author first, please.]

1Department of Perseverance, University of Hard Knocks, London, England;
2The Severus Snape School of Pills & Potions, Hogwarts School of Witchcraft and Wizardry; 32nd year pharmacy student, Unseen University, Discworld

[*IF A SINGLE INSTITUTION
Bloggs J., Jones M., and Smith F.

Department of Endeavour, University of Hard Knocks, London, England]

Introduction or Background (if relevant):

Aim:

Methods:

Results:

Conclusion:

REFERENCES: [Please see extra info on references, overleaf.]

Table (if any). The abstracts are submitted for publication as a continuous document and the publisher requires that any tables appear at the end of individual abstracts. If you wish to insert them elsewhere for display at the conference you will be asked to move them and resend the entire abstract at the appropriate time. [Please see extra info on tables, overleaf.]

Examples of formatting for references – please follow, including italics and bold

1. Hempel S, Newberry SJ, Maher AR, Wang Z, et al., ‘Probiotics for the
prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis’, JAMA, 2012; 307(18):1959-1969.

2. American Association of Clinical Endocrinologists and American College of
Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of
Postmenopausal Osteoporosis (2016). Camacho PM, et al.

3. HSCIC 2014. Health Survey for England – 2013. Health & Social Care
Information Centre.

4. PSNC. New guidance on MURs. http://psnc.org.uk/services-commissioning/
advanced-services/murs/national-target-groups-for-murs/ (Accessed 17th October 2016).

5. Knapper CK and Cropley A, 1991: Lifelong Learning and Higher Education. London: Croom Helm.

Further instructions regarding tables

Any tables should be simple.

• Tables should be supplied as Tab-spaced text (not key-spaced), or as WORD tables, i.e. not pasted in from other applications
• Carriage returns should not be used within cells
• Tables will be reduced to fit a single column of the final publication in Pharmacoepidemiology & Drug Safety
• If figures are necessary, they should be of high quality, and lettering/symbols/lines should be clear and distinct as they will be reduced to one column width for publication, and there will not be sufficient time to revise them. By default they will be printed in black and white (fine in colour for display at the conference)

Please ensure that all special characters/symbols/artwork are retained in the electronic copy, and as a precaution, hard copy should be supplied for reference if special characters have been used.
If necessary, specify any special characters used to represent non-keyboard characters, or use ASCII codes.

Take care not to use I (cap i) or l (ell) for 1 (one), O (capital o) for 0 (zero) or ß (German esszett) for (beta).

If your poster is selected to be displayed at the meeting, it must be brought by yourself as a size A0 poster. Adhesive stickers will be provided to display your poster.

Please email primmad17@gmail.com if you require any further help.